Is Lennar The Best Way to Profit From Homebuilding?

Fiscal cliff? Hard landing in China? Tell that to the American consumer. Alongside generally good confidence and retail sales numbers, housing starts have begun to tick back up and increased 15% between August and September. This corresponds with quarterly reports from large banks, which generally noted positive developments in the housing market. Lennar Corporation (NYSE:LEN), a $7.3 billion market cap homebuilder which also provides mortgage lending and other real estate services, was up about 2% on the day. It is now up about 140% in the last 52 weeks.

DUQUESNE CAPITAL

Lennar’s third fiscal quarter, which ended in August, showed an increase in revenue of 34% compared to the third quarter of 2011. This brought top-line growth through the first three quarters of the fiscal year to 29%, suggesting that activity was accelerating even at that time. As a result of this growth, the company pulled what had been low earnings numbers in 2011 up quite substantially: in the third quarter, for example, net income increased from $21 million a year earlier to $87 million. Business was particularly strong in south Florida and Houston. Lennar Corporation trades at 14 times trailing earnings, but with the sell-side expecting business in its next fiscal year to be significantly cooler its forward P/E is a considerably higher 24. That trailing multiple is very reasonable given the company’s growth, and while we are aware that homebuilding is cyclical and the growth trend won’t be continuing for the next ten years it is still an attractive feature.

A number of hedge funds and other notable investors piled into Lennar Corporation during the second quarter of 2012. Billionaire Stanley Druckenmiller initiated a position of 3.3 million shares, which meant that at the end of June he had $100 million invested in the stock; it was his second largest 13F position by market value (see more stock picks from Stanley Druckenmiller). Ken Heebner’s Capital Growth Management had owned a small position in the stock and increased it over the course of the second quarter to a total of 4.2 million shares (research more stocks that Capital Growth Management bought). Citadel Advisors, managed by billionaire Ken Griffin, more than doubled the size of its own stake in the stock (find other stocks that Ken Griffin liked).

We would compare Lennar to fellow homebuilders D.R. Horton, Inc. (NYSE:DHI), Toll Brothers Inc (NYSE:TOL), PulteGroup, Inc. (NYSE:PHM), and KB Home (NYSE:KBH). The latter two of these companies are unprofitable on a trailing basis, but grew their revenues 15-16% in their most recent quarter versus the same period a year ago and Wall Street analysts expect them to be profitable in their next fiscal year: KB Home barely so, and PulteGroup enough to drive a forward P/E of 19. KB Home is also a significantly smaller company in terms of market cap, with its equity valued at $1.3 billion, so perhaps it is not as good a buy. PulteGroup’s discount relative to Lennar on a forward earnings basis is interesting, but it is based on an expectation that it will improve its business while Lennar declines. We’d need to investigate further to check on that assumption.

D.R. Horton looks a bit similar to Lennar: a low trailing P/E, but with consensus implying that it trades at 24 times forward earnings. Its revenue was 15% higher in its most recent quarterly report compared to the same period in 2011, with a large percentage increase in earnings. In this case there’s little on the surface to make one or the other more attractive. Toll Brothers, which concentrates on higher-end residential developments, is high priced at 32 times forward earnings estimates but has seen very high revenue and earnings growth recently. We think it warrants a slightly higher multiple for its higher-priced focus, but probably not to the degree that we see in the market.

Lennar actually seems to be one of the better picks in the homebuilding industry, with D.R. Horton seeming to be at about the same value and PulteGroup requiring further analysis to make a judgment call. It does look a bit expensive on a forward earnings basis, but given the depth of the housing decline the company may be able to prove fairly valued in the event of a sustained recovery.

Biotech Insider Alert - $6 Stock To Hit $40

$200 Million Dollar Healthcare Hedge Fund's #1 Best Idea Right Now

The best healthcare hedge fund out there right now is one of the largest shareholders in this biotech stock. The fund returned more than 20% in each of the last 2 years with a virtually fully hedged portfolio, and it's sending out a BUY signal on this biotech stock. Get your FREE REPORT today (retail value of $300)

This is a FREE report from Insider Monkey. Credit Card is NOT required.
Comments
Insider Monkey Small Cap Strategy
Insider Monkey Small Cap Strategy

Insider Monkey beat the market by 52 percentage points in 24 months. Our beta is only 1.2 (don't click this link if beating the market isn't important to you).

Lists

The Best Romance Movies of all Time

The Most Wanted Drug Lords

The Oldest Money Managers

The Greatest Directors in the World

Largest Animals in the World

World’s Most Expensive Desserts

Best Selling Comic Books of All Time

A-list Actors who Sabotaged Their Career

Rappers With a College Degree

The Best Jazz Albums of all Time

The Most Influential Jazz Musicians

The World’s Most Famous Photographers

The Best Oscar-Winning Songs

Most Influential Choreographers Ever

Most Expensive Department Stores in the World

The Most Expensive Stolen Paintings in the World

The World’s Most Expensive Teas

Top Oscar Record Holders

The Most Expensive Flowers in the World

Countries With a Booming Film Industry

Most Expensive Cupcakes in the World

Uncommon European Escapes

The Most Stolen Artists in History

Best Travel Destinations in Australia

World’s Most Expensive Musical Instruments

World’s Most Famous Animals

Most Expensive Cakes in the World

Most Expensive Kosher Champagne in the World

Most Expensive Kosher Wine in the World

The Most Surprisingly Dark Fairy Tales

Most Popular Travel Destinations in Asia

The 10 Most Expensive Dresses Ever Worn to the Oscars

World’s Most Visited Art Museums

Best Countries for Photographers to Work in

Best Paid Jobs in the Film Industry

The Most Renowned Recovered Paintings Ever

Child Stars That Turned out Just Fine

Books That Were Banned in the Past Century

World’s Richest Dancers

Best Remedies against Bad Breath

Foods That Improve Your Skin Texture

Best-Selling Children’s Books of all Time

Foods That Boost Your Libido

Best-Selling Books of all Time

The Most Expensive Academy Awards Jewelry in History

Most Expensive Japanese Restaurant In New York City

The Best B-Boy Movies

Most Awesome Hip Hop Documentaries

Foods That Stain Your Teeth

Richest Doctors in the World

Subscribe

Enter your email:

Delivered by FeedBurner

X

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 129% in 2.5 years!! Wondering How?

Download a complete edition of our newsletter for free!